Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Riener MO et al. – The comprehensive study shows that IMP3 is an independent prognostic biomarker in bile duct carcinoma. In addition, it may be a marker for high–grade dysplasia in the extrahepatic biliary tract.

Related Articles

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
British Journal of Cancer, 11/13/09    Relevance Score: 79%

Biliopancreatic fistula and abscess formation in the bursa omentalis associated with intraductal papillary mucinous cancer of the pancreas
International Journal of Clinical Oncology, 10/30/09    Relevance Score: 79%

Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study
Modern Pathology, 11/19/09    Relevance Score: 68%

Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09    Relevance Score: 68%

Laser-Guided Repair of Complex Bile Duct Strictures
Digestive Surgery, 11/16/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address